Estrogen Plus Progestin Therapy and Breast Cancer in Recently Postmenopausal Women

The Women’s Health Initiative trial found a modestly increased risk of invasive breast cancer with daily 0.625-mg conjugated equine estrogens plus 2.5-mg medroxyprogesterone acetate, with most evidence among women who had previously received postmenopausal hormone therapy. In comparison, observation...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Prentice, Ross L., Chlebowski, Rowan T., Stefanick, Marcia L., Manson, JoAnn E., Pettinger, Mary, Hendrix, Susan L., Hubbell, F. Allan, Kooperberg, Charles, Kuller, Lewis H., Lane, Dorothy S., McTiernan, Anne, O’Sullivan, Mary Jo, Rossouw, Jacques E., Anderson, Garnet L.
Format: Artigo
Jezik:Inglês
Izdano: 2008
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2670848/
https://ncbi.nlm.nih.gov/pubmed/18372396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwn044
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items